NeuRizer Ltd. (NRZ.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 31.45 Thousand | 45.38 Thousand | 158.52 Thousand | 179.73 Thousand | 77.67 Thousand | 59.11 Thousand |
| Gross Profit | -31.45 Thousand | -45.38 Thousand | -158.52 Thousand | -179.73 Thousand | -77.67 Thousand | -59.11 Thousand |
| Operating Expenses | 2.76 Million | 13.53 Million | 12.45 Million | 8.9 Million | 7.07 Million | 7.49 Million |
| Selling, General and Administrative Expenses | 2.76 Million | 13.53 Million | 9.12 Million | 7.27 Million | 5.41 Million | 5.58 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 983.75 Thousand | - | 50.5 Thousand | 50 Thousand | 13.45 Thousand |
| Cost and Expenses | 2.79 Million | 13.58 Million | 12.45 Million | 8.9 Million | 7.07 Million | 7.49 Million |
| Operating Income | -2.79 Million | -13.58 Million | -12.45 Million | -8.86 Million | -7 Million | -7.37 Million |
| Interest Expense | 1.09 Million | 3.66 Million | 7.94 Million | 4.71 Million | 150.71 Thousand | 2.16 Million |
| Income Tax Expense | -1.71 Million | 4.00 | -69.96 Thousand | 4.76 Million | 200.71 Thousand | 2.17 Million |
| Earnings before Tax | -5.6 Million | -16.26 Million | -20.39 Million | -13.57 Million | -7.15 Million | -9.53 Million |
| Net Income | -5.6 Million | -16.26 Million | -20.39 Million | -13.57 Million | -7.15 Million | -9.53 Million |
| Earnings Per Share Basic | -0.00 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.00 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 1.42 Billion | 1.03 Billion | 823.81 Million | 658.34 Million | 567.4 Million | 433.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.42 Billion | 1.03 Billion | 823.81 Million | 658.34 Million | 567.4 Million | 433.28 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4.47 Million | -13.53 Million | -12.29 Million | -8.67 Million | -6.92 Million | -7.43 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 24.33 Thousand | 7123.00 | - | - | 45.38 Thousand | - |
| Gross Profit | -24.33 Thousand | -7123.00 | - | - | -45.38 Thousand | - |
| Operating Expenses | 2.16 Million | 301.59 | 322.64 | 4.75 Million | 13.53 Million | 3466.73 |
| Selling, General and Administrative Expenses | 2.16 Million | 130.25 | 130.25 | 4.75 Million | - | 2030.94 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 171.34 | - | - | 983.75 Thousand | - |
| Cost and Expenses | 2.19 Million | 301.59 | 322.64 | 4.75 Million | 13.58 Million | 3466.73 |
| Operating Income | -2.19 Million | -301.59 | -301.57 | -4.75 Million | -13.58 Million | -2377.17 |
| Interest Expense | 2.8 Million | - | - | 3.13 Million | 3.66 Million | - |
| Income Tax Expense | 198.49 Thousand | -3.00 | - | 4.75 Million | 4.00 | - |
| Earnings before Tax | -4.8 Million | -399.57 | -399.57 | -6.89 Million | -16.26 Million | -3449.66 |
| Net Income | -4.8 Million | -399.57 | -399.57 | -6.89 Million | -16.26 Million | -3449.66 |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.01 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.01 | - | -0.00 |
| Weighted Average Shares Outstanding | 1.45 Billion | 1.28 Billion | 1.28 Billion | 1.24 Billion | 1.03 Billion | 1.07 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.45 Billion | 1.28 Billion | 1.28 Billion | 1.24 Billion | 1.03 Billion | 1.07 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.97 Million | -298.01 | -298.01 | -2365.83 | - | -2361.50 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
TOIPY
RNGR
9528
TRMD-A
FRU
MRGE